Agree with most of your comment. The USA sales team should be in business now. Nothing they like better than a good product and they will have 3 or 4 such products soon to sell. I would like to see progress in Europe with the sales and regulatory approvals. We need to get VasCucel into that ageing market.
We need to outsource the vaccine /immunotherapy business , take a down payment and enjoy the future royalties. Does WP have skin in the game as you alluded to?
Lets actually take a closer look, page-39
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |